According to previous study, progranulin was shown to regulate retinal regeneration through the c-met receptor [25], and recent studies have also revealed that progranulin is upregulated by IL-6 to promote cholangiocarcinoma, a type of liver cancer with high mortality, although progranulin was previously regarded as a promising therapeutic target [26,27]. This evidence concerns the gene GRN and cholangiocarcinoma.